Alcon (ALC) Net Income towards Common Stockholders (2009 - 2026)
Alcon (ALC) posted quarterly Net Income towards Common Stockholders of $22.1 billion for Q1 2026, up 10099.08% on a QoQ basis from $217.0 million in Q4 2025.
Alcon (ALC) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Net Income towards Common Stockholders for 11 consecutive years, with $22.1 billion the latest figure, recorded in Q1 2026.
- Quarterly Net Income towards Common Stockholders changed N/A year-over-year to $22.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $66.5 billion (up 8542.73% YoY) and the FY2025 annual result came in at $22.0 billion, up 2.23% from the prior year.
- Net Income towards Common Stockholders grew to $22.1 billion in Q1 2026 per ALC's latest filing, from $217.0 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for ALC reached as high as $22.1 billion in Q1 2026 and fell as low as -$31.0 million in Q4 2022.
- A 5-year average of $4.3 billion and a median of $220.0 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders plunged 121.99% — and 2025, when it jumped 9816.59%.
- Year by year, Net Income towards Common Stockholders stood at -$31.0 million in 2022, then soared by 641.94% to $168.0 million in 2023, then surged by 69.05% to $284.0 million in 2024, then slipped by 23.59% to $217.0 million in 2025, then jumped by 10099.08% to $22.1 billion in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $22.1 billion, $217.0 million, and $22.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.19 Bn | 120.97 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.76 Bn | 43.95 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.93 Bn | 31.28 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.80 Bn | 30.56 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.51 Bn | 27.85 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.59 Bn | 23.15 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.01 Bn | 13.45 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.77 Bn | 13.63 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Baxter International | 12.03 Bn | 10.01 Bn | 891.00 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.13 Bn |
| Dec 31, 2025 | 217.00 Mn |
| Sep 30, 2025 | 22.09 Bn |
| Jun 30, 2025 | 22.11 Bn |
| Dec 31, 2024 | 284.00 Mn |
| Sep 30, 2024 | 263.00 Mn |
| Jun 30, 2024 | 223.00 Mn |
| Mar 31, 2024 | 248.00 Mn |
| Dec 31, 2023 | 168.00 Mn |
| Sep 30, 2023 | 238.00 Mn |
| Jun 30, 2023 | 169.00 Mn |
| Mar 31, 2023 | 213.00 Mn |
| Dec 31, 2022 | -31.00 Mn |
| Sep 30, 2022 | 147.00 Mn |
| Jun 30, 2022 | 148.00 Mn |
| Mar 31, 2022 | 200.00 Mn |
| Dec 31, 2021 | 141.00 Mn |
| Sep 30, 2021 | -23.00 Mn |
| Jun 30, 2021 | 151.00 Mn |
| Mar 31, 2021 | 109.00 Mn |